1. Home
  2. /
  3. Venture Capital
  4. /
  5. MRM Health starts clinical...

Venture Capital

MRM Health starts clinical trial Pouchitis

27 July 2022
MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced today that they have received regulatory approval from the Federal Agency for Medicines and Health Products (FAMHP) in Belgium to start a Phase 2 trial with the novel next-generation optimized consortium therapy, MH002, in patients with Pouchitis.

Download

Press Release
Download

Related News

arrow-up-right
arrow-up-right
arrow-up-right